Skip to content
Disclosery

EXANE DERIVATIVES: ARGX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ARGX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 6 ARGX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 6 shares
    Change vs previous 13F -105 shares

    <0.01% of the 13F portfolio, value $2,273.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 111 shares
    Change vs previous 13F -31 shares

    0.01% of the 13F portfolio, value $34,997.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 142 shares
    Change vs previous 13F -287 shares

    0.01% of the 13F portfolio, value $49,725.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 429 shares
    Change vs previous 13F -79 shares

    0.03% of the 13F portfolio, value $129,553.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 508 shares
    Change vs previous 13F +71 shares

    0.04% of the 13F portfolio, value $156,369.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 437 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $120,339.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).